CA-19-9 AND CEA IN THE DIFFERENTIAL-DIAGNOSIS OF ISOLATED LIVER METASTASES COMPARED TO CLINICAL LABORATORY TESTS

被引：0
|
作者：
LORENZ, M
HOTTENROTT, C
BAUM, RP
MAUL, FD
KIRKOWAREIMANN, M
HOR, G
ENCKE, A
机构：
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 1987年 / 8卷 / 10期
关键词：
D O I：
10.1097/00006231-198710000-00004
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：787 / 796
页数：10
相关论文
共 50 条
  • [31] THE ROLE OF THE LEUKOCYTE ADHERENCE INHIBITION (LAI), CA-19-9, AND TISSUE POLYPEPTIDE ANTIGEN (TPA) TESTS IN THE DIAGNOSIS OF PANCREATIC-CANCER
    MEDURI, F
    DONI, MG
    MERENDA, R
    BIZZARINI, M
    NERI, D
    GERUNDA, GE
    FACCIOLI, AM
    CANCER, 1989, 64 (05) : 1103 - 1106
  • [32] TUMOR-MARKERS IN THE DIAGNOSIS AND FOLLOW-UP OF HEAD AND NECK-CANCER - ROLE OF CEA, CA-19-9, SCC, TK, AND DTTPASE
    WALTHER, EK
    DAHLMANN, N
    GORGULLA, HT
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1993, 15 (03): : 230 - 235
  • [33] THE DIFFERENTIAL DIAGNOSIS OF JAUNDICE - THE RELATIVE VALUE OF THE CLINICAL IMPRESSION, LABORATORY TESTS, AND ASPIRATION LIVER BIOPSY
    TYOR, MP
    CAYER, D
    GASTROENTEROLOGY, 1953, 24 (01) : 63 - 70
  • [34] Clinical utility of serum CEA, CA72-4 and CA19-9 in the diagnosis and staging of gastric carcinoma.
    Park, S
    Park, S
    Park, M
    Kim, Y
    Koo, J
    GASTROENTEROLOGY, 2000, 118 (04) : A266 - A266
  • [35] PROSPECTIVE CLINICAL-EVALUATION OF THE DIAGNOSTIC-ACCURACY OF MONOCLONAL (CA-19-9, CA-50, CA-12-5) AND POLYCLONAL (CEA, TPA) ANTIGENS IN RESPECT TO PANCREATIC-CARCINOMA
    BENINI, L
    CAVALLINI, G
    ZORDAN, D
    RIGO, L
    RIZZOTTI, P
    PEROBELLI, L
    BROCCO, G
    PEDERZOLI, P
    RIELA, A
    SCURO, LA
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1987, 19 (01): : 54 - 55
  • [36] Isolated splenic metastasis from gastric carcinoma - Value of CEA and CA 19-9 in early diagnosis: Report of two cases
    Opocher, E
    Santambrogio, R
    Bianchi, P
    Cioffi, U
    De Simone, M
    Vellini, S
    Montorsi, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (06): : 579 - 580
  • [37] QUANTITATIVE-DETERMINATION OF UPTAKE OF I-131-LABELED ANTI-CEA AND CA 19-9 IN LIVER METASTASES USING SPECT
    LEINSINGER, G
    KIRSCH, CM
    KRAGH, P
    PLETZER, G
    LECHEL, U
    ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1991, 4 (04): : 665 - 671
  • [38] Development of tumor marker ELISA tests for the direct quantitation. of CA 19-9, CA 125, CEA, AFP, and total PSA in clinical routine.
    Janetzko, A
    Bauer, K
    Dudek, T
    Brahms, H
    Geacintov, CE
    CLINICAL CHEMISTRY, 2005, 51 : A58 - A58
  • [39] Preoperative differential diagnosis of benign and malignant pancreatic lesions - The value of pancreatic secretory trypsin inhibitor, Procarboxypeptidase B, CA19-9 and CEA
    Cerwenka, H
    Aigner, R
    Quehenberger, F
    Werkgartner, G
    Bacher, H
    Hauser, H
    Mischinger, HJ
    HEPATO-GASTROENTEROLOGY, 1997, 44 (16) : 1117 - 1121
  • [40] Clinical Value of Combined Detection of Serum sTim-3 and CEA or CA19-9 for Postoperative Recurrence of Colorectal Cancer Diagnosis
    Hong, Jianfeng
    Chen, Xindong
    Chen, Lingli
    Wang, Yigang
    Huang, Biao
    Fang, Hongming
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 563 - 572
12345